Nanoinjection: A Platform for Innovation in Ex Vivo Cell Engineering
Open Access
- 31 May 2024
- journal article
- review article
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 57 (12) , 1722-1735
Abstract
ConspectusIn human cells, intracellular access and therapeutic cargo transport, including gene-editing tools (e.g., CRISPR-Cas9 and transposons), nucleic acids (e.g., DNA, mRNA, and siRNA), peptides, and proteins (e.g., enzymes and antibodies), are tightly constrained to ensure healthy cell function and behavior. This principle is exemplified in the delivery mechanisms of chimeric antigen receptor (CAR)-T cells for ex-vivo immunotherapy. In particular, the clinical success of CAR-T cells has established a new standard of care by curing previously incurable blood cancers. The approach involves the delivery, typically via the use of electroporation (EP) and lentivirus, of therapeutic CAR genes into a patient's own T cells, which are then engineered to express CARs that target and combat their blood cancer. But the key difficulty lies in genetically manipulating these cells without causing irreversible damage or loss of function─all the while minimizing complexities of manufacturing, safety concerns, and costs, and ensuring the efficacy of the final CAR-T cell product.Nanoinjection─the process of intracellular delivery using nanoneedles (NNs)─is an emerging physical delivery route that efficiently negotiates the plasma membrane of many cell types, including primary human T cells. It occurs with minimal perturbation, invasiveness, and toxicity, with high efficiency and throughput at high spatial and temporal resolutions. Nanoinjection promises greatly improved delivery of a broad range of therapeutic cargos with little or no damage to those cargos. A nanoinjection platform allows these cargos to function in the intracellular space as desired. The adaptability of nanoinjection platforms is now bringing major advantages in immunomodulation, mechanotransduction, sampling of cell states (nanobiopsy), controlled intracellular interrogation, and the primary focus of this account─intracellular delivery and its applications in ex vivo cell engineering.Mechanical nanoinjection typically exerts direct mechanical force on the cell membrane, offering a straightforward route to improve membrane perturbation by the NNs and subsequent transport of genetic cargo into targeted cell type (adherent or suspension cells). By contrast, electroactive nanoinjection is controlled by coupling NNs with an electric field─a new route for activating electroporation (EP) at the nanoscale─allowing a dramatic reduction of the applied voltage to a cell and so minimizing post-EP damage to cells and cargo, and overcoming many of the limitations of conventional bulk EP. Nanoinjection transcends mere technique; it is an approach to cell engineering ex vivo, offering the potential to endow cells with new, powerful features such as generating chimeric antigen receptor (CAR)-T cells for future CAR-T cell technologies.We first discuss the manufacturing of NN devices (Section 2), then delve into nanoinjection-mediated cell engineering (Section 3), nanoinjection mechanisms and interfacing methodologies (Section 4), and emerging applications in using nanoinjection to create functional CAR-T cells (Section 5).Keywords
Funding Information
- Australian Research Council (FT220100749, IC190100026)
- Australian National Fabrication Facility
- Vic Tech Ambassador Program for Deakin University
- Deakin's Institute of Frontier Materials
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University
- Melbourne Centre for Nanofabrication in the Victorian Node of the Australian National Fabrication Facility
- Deakin's School of Medicine
This publication has 101 references indexed in Scilit:
- Polymeric Nanoneedle Arrays Mediate Stiffness‐Independent Intracellular DeliveryAdvanced Functional Materials, 2021
- Nanowire Based Mechanostimulating Platform for Tunable Activation of Natural Killer CellsAdvanced Functional Materials, 2021
- Nanoneedle Platforms: The Many Ways to Pierce the Cell MembraneAdvanced Functional Materials, 2020
- Nanoscale Mechanosensing of Natural Killer Cells is Revealed by Antigen‐Functionalized NanowiresAdvanced Materials, 2018
- Maximizing Transfection Efficiency of Vertically Aligned Silicon Nanowire ArraysAdvanced Functional Materials, 2015
- Spatially, Temporally, and Quantitatively Controlled Delivery of Broad Range of Molecules into Selected Cells through Plasmonic NanotubesAdvanced Materials, 2015
- Mapping Local Cytosolic Enzymatic Activity in Human Esophageal Mucosa with Porous Silicon NanoneedlesAdvanced Materials, 2015
- Intracellular Delivery of Bioactive Cargos to Hard‐to‐Transfect Cells Using Carbon Nanosyringe Arrays under an Applied Centrifugal g‐ForceAdvanced Healthcare Materials, 2015
- Biodegradable Porous Silicon Barcode Nanowires with Defined GeometryAdvanced Functional Materials, 2010
- Vector unpacking as a potential barrier for receptor-mediated polyplex gene deliveryBiotechnology and Bioengineering, 2000